KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Other Non-Current Assets (2020 - 2025)

AbCellera Biologics' Other Non-Current Assets history spans 6 years, with the latest figure at $53.1 million for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets fell 60.46% year-over-year to $53.1 million, compared with a TTM value of $53.1 million through Sep 2025, down 60.46%, and an annual FY2024 reading of $27.3 million, down 71.03% over the prior year.
  • Other Non-Current Assets for Q3 2025 was $53.1 million at AbCellera Biologics, down from $57.5 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $134.2 million in Q3 2024, with the low at $1.8 million in Q2 2022.
  • Average Other Non-Current Assets over 5 years is $55.0 million, with a median of $43.4 million recorded in 2022.
  • Year-over-year, Other Non-Current Assets tumbled 88.56% in 2022 and then skyrocketed 6119.63% in 2023.
  • Tracing ABCL's Other Non-Current Assets over 5 years: stood at $25.0 million in 2021, then grew by 12.4% to $28.1 million in 2022, then skyrocketed by 235.39% to $94.2 million in 2023, then tumbled by 71.03% to $27.3 million in 2024, then skyrocketed by 94.38% to $53.1 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Other Non-Current Assets are $53.1 million (Q3 2025), $57.5 million (Q2 2025), and $61.6 million (Q1 2025).